✦ LIBER ✦

Treatment persistence higher with ibandronic acid + patient support than alendronic acid

Book ID: 120850098
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2006
Weight: 133 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200615540-00040

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment persistence with once-monthly

Treatment persistence with once-monthly ibandronate and patient support vs. once-weekly alendronate: results from the PERSIST study

✍ A. COOPER; J. DRAKE; E. BRANKIN; THE PERSIST INVESTIGATORS 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

Oral tranexamic acid as a novel treatmen

Oral tranexamic acid as a novel treatment option for persistent haematuria in patients with sickle cell disease

✍ Niall F. Davis; Barry B. McGuire; Leo Lawlor; Peter O’Gorman; Kiaran J. O’Malley 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 59 KB

PHP36 Comparing Oral 5-Aminosalicylic Ac

PHP36 Comparing Oral 5-Aminosalicylic Acid Treatment Persistence and Adherence in Patients with Ulcerative Colitis in the United States

✍ Yen, L.; Wu, J.; Hodgkins, P.; Nichol, M.B. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

Metronomic Adjuvant Chemotherapy Improve

Metronomic Adjuvant Chemotherapy Improves Treatment Outcome in Nasopharyngeal Carcinoma Patients With Postradiation Persistently Detectable Plasma Epstein-Barr Virus Deoxyribonucleic Acid

✍ Twu, Chih-Wen; Wang, Wen-Yi; Chen, Chien-Chih; Liang, Kai-Li; Jiang, Rong-San; W 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 569 KB

Treatment Persistence With Monthly Zoled

Treatment Persistence With Monthly Zoledronic Acid is Associated With Lower Risk and Frequency of Skeletal Complications in Patients With Breast Cancer and Bone Metastasis

✍ Hind T. Hatoum; Swu-Jane Lin; Matthew R. Smith; Amy Guo; Allan Lipton 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 374 KB

Long-term outcomes after treatment with

Long-term outcomes after treatment with external beam radiation therapy and palladium 103 for patients with higher risk prostate carcinoma : Influence of prostatic acid phosphatase

✍ Michael Dattoli; Kent Wallner; Lawrence True; Jennifer Cash; Richard Sorace 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this study was to define the long‐term prognostic significance of prostatic acid phosphatase (PAP) levels in patients with higher risk, early‐stage prostate carcinoma. ## METHODS One hundred sixty‐one consecutive patients with Stage T1–T3 prostate carci